Page last updated: 2024-09-05

anidulafungin and Adverse Drug Event

anidulafungin has been researched along with Adverse Drug Event in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ding, D; Fang, H; Kelly, R; Liu, Z; Shi, Q; Tong, W1
Aram, JA; Capparella, MR; Montravers, P; Sganga, G; Tawadrous, M; Wang, M; Yan, JL1
Aram, JA; Lee, DG; Lee, HJ; Lin, SS; Yan, JL1
Jiang, Y; Jung, DS; Kontoyiannis, DP; Tverdek, FP1
George, J; Reboli, AC1
Auzinger, G; Borges Sá, M; Dimopoulos, G; Grigoras, I; Kantecki, M; Marček, T; Meersseman, W; Menichetti, F; Miller, PJ; Montravers, P; Pachl, J; Paiva, JA; Ruhnke, M; Sganga, G1
Auzinger, G; Dimopoulos, G; Grigoras, I; Kantecki, M; Marček, T; Meersseman, W; Miller, PJ; Montravers, P; Pachl, J; Paiva, JA; Ruhnke, M; Sá, MB; Sganga, G1

Reviews

1 review(s) available for anidulafungin and Adverse Drug Event

ArticleYear
Anidulafungin: when and how? The clinician's view.
    Mycoses, 2012, Volume: 55, Issue:1

    Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Drug Resistance, Fungal; Drug Synergism; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2012

Trials

3 trial(s) available for anidulafungin and Adverse Drug Event

ArticleYear
Efficacy and safety of combination antifungal therapy in Korean haematological patients with invasive aspergillosis.
    Mycoses, 2019, Volume: 62, Issue:10

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Asian People; Double-Blind Method; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Hematologic Neoplasms; Humans; Immunocompromised Host; Invasive Pulmonary Aspergillosis; Male; Middle Aged; Placebos; Survival Analysis; Treatment Outcome; Voriconazole; Young Adult

2019
Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients.
    Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2012, Volume: 18, Issue:7

    Topics: Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candida; Candidiasis, Invasive; Critical Illness; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Female; Fluconazole; Humans; Male; Middle Aged; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole

2012
Efficacy and safety of anidulafungin in elderly, critically ill patients with invasive Candida infections: a post hoc analysis.
    International journal of antimicrobial agents, 2012, Volume: 40, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candidiasis, Invasive; Critical Illness; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Female; Humans; Incidence; Male; Middle Aged; Survival Analysis; Treatment Outcome

2012

Other Studies

3 other study(ies) available for anidulafungin and Adverse Drug Event

ArticleYear
Translating clinical findings into knowledge in drug safety evaluation--drug induced liver injury prediction system (DILIps).
    PLoS computational biology, 2011, Volume: 7, Issue:12

    Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Chemical and Drug Induced Liver Injury; Databases, Factual; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Models, Biological; Predictive Value of Tests

2011
Evaluation of anidulafungin in the treatment of intra-abdominal candidiasis: a pooled analysis of patient-level data from 5 prospective studies.
    European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 2019, Volume: 38, Issue:10

    Topics: Administration, Intravenous; Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candida; Candidiasis; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Intraabdominal Infections; Male; Middle Aged; Prospective Studies; Surgical Wound Infection; Treatment Outcome; Young Adult

2019
Switching to anidulafungin from caspofungin in cancer patients in the setting of liver dysfunction is associated with improvement of liver function tests.
    The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Anidulafungin; Caspofungin; Chemical and Drug Induced Liver Injury; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Female; Humans; Lipopeptides; Liver Function Tests; Male; Middle Aged; Mycoses; Neoplasms; Retrospective Studies; Young Adult

2015